tiprankstipranks
Advertisement
Advertisement

DE:6OP Stock Latest News

OSE Immunotherapeutics Showcases Lead IBD Drug Lusvertikimab in Upcoming KOL Webcast
Company AnnouncementsOSE Immunotherapeutics Showcases Lead IBD Drug Lusvertikimab in Upcoming KOL Webcast
10d ago
OSE Immunotherapeutics Updates Share Capital and Voting Rights After New Equity Issuance
PremiumCompany Announcements
OSE Immunotherapeutics Updates Share Capital and Voting Rights After New Equity Issuance
12d ago
Ose Immunotherapeutics resumed with a Buy at Kepler Cheuvreux
PremiumThe Fly
Ose Immunotherapeutics resumed with a Buy at Kepler Cheuvreux
6M ago
OSE Immunotherapeutics Advances Phase 3 Trial for NSCLC Vaccine
PremiumCompany Announcements
OSE Immunotherapeutics Advances Phase 3 Trial for NSCLC Vaccine
12M ago
6OP
PremiumCompany Announcements
OSE Immunotherapeutics’ Phase 3 Trial: A New Hope for NSCLC Patients
1y ago
PremiumCompany AnnouncementsOSE Immunotherapeutics Advances in NSCLC Treatment with Phase 3 Trial of OSE2101
1y ago
Premium
Company Announcements
OSE Immunotherapeutics Advances Cancer Vaccine Trial: Potential Market Impact
1y ago
OSE Immunotherapeutics Advances Phase 3 Trial for Promising Lung Cancer Vaccine
Premium
Company Announcements
OSE Immunotherapeutics Advances Phase 3 Trial for Promising Lung Cancer Vaccine
1y ago
PremiumCompany Announcements
OSE Immunotherapeutics Advances Phase 3 Trial for NSCLC Vaccine
1y ago
PremiumCompany Announcements
OSE Immunotherapeutics’ Phase I Study Update: Exploring New Cancer Treatments
1y ago
Promising Clinical Trial Results and Strategic Positioning Propel OSE Immunotherapeutics SA to a Buy Rating
PremiumRatings
Promising Clinical Trial Results and Strategic Positioning Propel OSE Immunotherapeutics SA to a Buy Rating
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >